Abstract
There are eight million blood donors in Japan. Blood is donated in units of 200 ml or 400 ml and by haemapheresis. The major problems are concerned with the transmission of infection, particularly with HIVandHTL-1 viral infections, and this leads to rejection of about 8% of donated blood. Recent emphasis has been placed on the automated screening of blood at the time of donation and the more widespread use of patient records to eliminate infected blood.
Résumé
Au Japon, huit millions de personnes donnent de leur sang que Ion preleve par hemopherese a raison de 200 ou 400 ml. On s’inquiète des risques de transmission infectieuse et plus particulièrement du HIV et du HTL-1, ce qui entraîne le rejet de 8% des unités. On a récemment mis l’accent sur le dépistage automatique lors du don de sang et sur un plus grand recours aux dossiers des patients afin réduire le risque d’infection.
Article PDF
Avoid common mistakes on your manuscript.
References
Nishioka K. Predominant mode of transmission of hepatitis B virus: perinatal transmission in Asia.In: Vyas DN, Dienstag JL, and Hofnagle JH. (Eds.). Viral Hepatitis and Liver Diseases. Orlando, Florida: Grune and Stratton 1984; 423–32.
Maeda Y, Furukawa M, Takehara Y et al. Prevalence of possible adult T-cell leukemia virus-carriers amoung volunteer blood donors in Japan: a nation-wide study. Int J Cancer 1984; 33: 717–20.
Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: scroconvcrsion in recipients. Vox Sang 1984; 46: 245–53.
Osame M, Usuku K, Izumo S et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1: 1031–2.
Sekiguchi S, Ikeda H, Kato T et al. An automated screening test for antibodies to human immunodeficiency virus-1. Transfusion 1988; 28: 581–5.
Leitman SF. Graft-versus-host disease and the role of blood product irradiation.In: Smit-Sibinga CT, Das PC, Engelfirct CP (Eds.). White cells and platelets in blood transfusion. Boston Martinus Niihoff 1987; 115–29.
Horowitz B, Wiebe ME, Lippin A et al. Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-envcloped viruses by tri (n-butyl) phosphate. Transfusion 1985; 25: 516–22.
Hamamoto Y, Harada S, Kobayashi S et al. A novel method for removal of human immunodeficiency virus (HIV): filtration with porous polymeric membrane. Vox Sang 1989; 56: 230–6.
Sekiguchi S, Ito K, Kobayashi M et al. Possibility of hepatitis B virus (HBV) removal from human plasma using regenerated cellulose hollow fiber (BMM). Membrane 1989; 14: 253–61.
Sirchia G, Rebella P, Parravicini A et al. Leukocyte depletion of red cell units at the bedside by transfusion through a new filter. Transfusion 1987; 27: 402–5.
Andrew G, DeWilly J, Leberre C et al. Prevention of HLA immunization with leukocyte poor packed red cells and platelet concentrates prepared by filtration. Blood 1988; 72: 964–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ikeda, H. Safety of blood transfusion: the Japanese experience. Can J Anaesth 38, 610–612 (1991). https://doi.org/10.1007/BF03008196
Issue Date:
DOI: https://doi.org/10.1007/BF03008196